Skip to main content

Table 3 Genotypic analyses of V1-V5 sequences

From: Genotypic and functional properties of early infant HIV-1 envelopes

Subjecta

V1-V5 lengthb*

V1-V5 PNGSc*

V3 charge

V3 glycan

V3 crown motifd

Tropisme

M1003

335

24 (23-25)

+3

Yes

APGR

R5

P1189

335

25 (25-25)

+3

Yes

APGR

R5

M1002

329 (329-333)

21 (20-24)

+3

Yes

GPGR

R5

P1031

329 (329-330)

19 (19-20)

+3

Yes

GPGR

R5

M1001

345 (342-347)

23 (22-25)

+2

Yes

GPGG, GPGR

R5

P1024

346 (345-346)

24 (23-24)

+2

Yes

GPGR

R5

M1007

328 (328-335)

23 (22-24)

+4

Yes

GPGR

R5

P1046

335

23 (21-23)

+4

Yes

GPGR

R5

M1006

332 (320-349)

24 (17-26)

+3 +4 +5

Yes, No

QPGR, QPGG

R5, R5/X4

P1049

332

24 (24-24)

+3

Yes

QPGR

R5

  1. aM, Mother; P, Infant.
  2. bMedian length of the env V1-V5 region as median (min-max).
  3. cMedian number of potential N-linked glycosylation sites in the V1-V5 region as median (min-max).
  4. dDominant variant presented first.
  5. eTropism determined in-vitro. R5, CCR5; R5/X4, CCR5/CXCR4.
  6. *p > 0.05. Pairwise differences between maternal and infant values were evaluated using Mixed Model ANOVA with mother-infant pairs included as random effects.